USFDA conducts inspection of Lupin's Mandideep Unit-1
Issues eight observation under Form 483
Lupin announced that the U.S. FDA inspected Lupin's Mandideep Unit-1 facility from 14 November 2022 to 23 November 2022. The inspection of the facility closed with issuance of a Form 483 with eight observations each for the Drug Product facility and API facility at the site.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 24 2022 | 6:53 PM IST